The FDA canceled an important meeting that could impact the flu vaccine for next winter, raising concerns about vaccine safety and efficacy under the trump administration. This decision comes during a severe flu season, leading to fears among health experts about production delays and potential consequences for public health.

Described in a negative light regarding its actions affecting the flu vaccine process.

Canceled a crucial meeting affecting flu vaccine composition.

Involved in the decision-making process for the seasonal flu vaccine.

Commented on the implications of the fda meeting cancellation regarding flu vaccine strain selection.

Newly appointed Health and Human Services Secretary, associated with anti-vaccine rhetoric.